Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: J Am Geriatr Soc. 2008 May 14;56(7):1228–1235. doi: 10.1111/j.1532-5415.2008.01753.x

Table 1.

Characteristics of 3051 Participants in Overall Cohort and According to Level of Depressive Symptoms

Level of Depressive Symptoms
Characteristic All Participants 0–2
(Normal)
3–5
(Some Depressive Symptoms)
≥6
(Depressed)
P-value
Number of participants 3051 2310 537 204
Age Groups, % <.001
 64–69 9 9 6 8
 70–74 34 36 31 25
 75–79 29 30 24 28
 ≥80 28 25 39 40
Race, % 0.305
 Caucasian 90 91 90 89
 African American 4 4 4 6
 Other 6 6 6 5
Self-reported health status, % <.001
 Excellent or Good 87 92 74 54
 Fair, Poor or Very Poor 13 8 26 46
Lives alone, % 13 12 15 22 <.001
Education, % <.001
 Less than high school 5 5 6 10
 High school diploma 16 15 21 18
 College/Graduate school 79 81 73 73
Alcohol intake, drinks/week, % <.001
 0–2 drinks per week 59 57 66 70
 3–13 drinks per week 35 37 31 26
 14 or more drinks per week 6 6 4 4
Smoking status, % 0.016
 Never Smoked 39 40 38 34
 Former Smokers 59 58 60 61
 Current Smokers 2 2 2 5
Caffeine intake, mg/day, mean ± SD 235.5 ± 245.9 238.3 ± 245.8 233.6 ± 249.3 208.8 ± 238.3 0.176
Current antidepressant use, % 8 5 13 25 <.001
Current benzodiazepine use, % 5 4 6 13 <.001
Current non-benzodiazepine anxiolytic/hypnotic use, % 2 2 3 3 0.026
Cognitively impaired (3MS score <80%), % 5 3 7 13 <.001
Body Mass Index, % 0.022
 Underweight/Normal weight (BMI <25) 30 30 30 27
 Overweight (BMI 25–30) 50 51 45 49
 Obese (BMI ≥30) 20 19 25 25
Systolic blood pressure, mean ± SD 126.9 ± 16.4 126.7 ± 16.0 127.4 ± 16.7 128.0 ± 19.8 0.441
Takes walks for exercise, % <.001
 Never 10 9 12 18
 Seldom (1–2 days/week) 17 15 20 24
 Sometimes (3–4 days/week) 27 26 30 27
 Often (5–7 days/week) 47 50 37 31
Any IADL impairments, % 21 15 36 54 <.001
≥1 selected medical conditions*, % 36 33 46 51 <.001
*

History of one or more selected medical conditions includes stroke, diabetes mellitus, Parkinsonism, chronic obstructive lung disease, congestive heart failure and myocardial infarction